ACTINIUM PHARMACEUTICALS INC - COM (ATNM)

CUSIP: 00507W107

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COM
Total 13F shares
2,501,778
Share change
-786,828
Total reported value
$6,628,915
Put/Call ratio
166%
Price per share
$2.65
Number of holders
38
Value change
-$1,979,311
Number of buys
24
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 00507W107?
CUSIP 00507W107 identifies ATNM - ACTINIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ACTINIUM PHARMACEUTICALS INC - COM (ATNM) as of Q2 2015

As of 30 Jun 2015, ACTINIUM PHARMACEUTICALS INC - COM (ATNM) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,501,778 shares. The largest 10 holders included VANGUARD GROUP INC, NORTHERN TRUST CORP, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, TIAA CREF INVESTMENT MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, DAFNA Capital Management LLC, BlackRock Fund Advisors, and MORGAN STANLEY. This page lists 38 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.